Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 970528, 6 pages
http://dx.doi.org/10.1155/2014/970528
Research Article

Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease

1Department of Digestive Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain
2CIBER Hepatic and Digestive Diseases (CIBEREHD), 07110 Bunyola, Balearic Islands, Spain
3Department of Clinical Microbiology and Infectious Diseases, General University Hospital Gregorio Marañón, Dr. Esquerdo 46, 28007 Madrid, Spain
4CIBER Respiratory Diseases (CIBERES CB06/06/0058), 07110 Bunyola, Balearic Islands, Spain
5Department of Medicine, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain
6Spanish Study Group on Infection in Transplant Recipients (GESITRA-RESITRA-REIPI), RD06/0008/1025, Spain

Received 11 November 2013; Accepted 24 December 2013; Published 13 February 2014

Academic Editors: D. P. Levine and A. Zakhartchouk

Copyright © 2014 Virginia Flores et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Gardner, A. M. Field, D. V. Coleman, and B. Hulme, “New human papovavirus (B.K.) isolated from urine after renal transplantation,” The Lancet, vol. 1, no. 7712, pp. 1253–1257, 1971. View at Google Scholar · View at Scopus
  2. H. H. Hirsch, D. C. Brennan, C. B. Drachenberg et al., “Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations,” Transplantation, vol. 79, no. 10, pp. 1277–1286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. H. H. Hirsch, “BK virus: opportunity makes a pathogen,” Clinical Infectious Diseases, vol. 41, no. 3, pp. 354–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Jiang, J. R. Abend, S. F. Johnson, and M. J. Imperiale, “The role of polyomaviruses in human disease,” Virology, vol. 384, no. 2, pp. 266–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. H. Hirsch and J. Steiger, “Polyomavirus BK,” Lancet Infectious Diseases, vol. 3, no. 10, pp. 611–623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Comoli, S. Binggeli, F. Ginevri, and H. H. Hirsch, “Polyomavirus-associated nephropathy: update on BK virus-specific immunity,” Transplant Infectious Disease, vol. 8, no. 2, pp. 86–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Megged, J. Stein, D. Ben-Meir et al., “BK-virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation,” Journal of Pediatric Hematology/Oncology, vol. 33, no. 3, pp. 190–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Giuliani, C. Ronci, D. Bonifacio et al., “Detection of oncogenic DNA viruses in colorectal cancer,” Anticancer Research, vol. 28, no. 2 B, pp. 1405–1410, 2008. View at Google Scholar · View at Scopus
  9. G. Y. Kim, J. Peji, G. Nuovo, and F. Thomas, “BK virus colonic ulcerations,” Clinical Gastroenterology and Hepatology, vol. 2, no. 2, pp. 175–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. R. F. Harvey and J. M. Bradshaw, “A simple index of Crohn's-disease activity,” The Lancet, vol. 1, no. 8167, p. 514, 1980. View at Google Scholar · View at Scopus
  11. M. S. Silverberg, J. Satsangi, T. Ahmad et al., “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology,” Canadian Journal of Gastroenterology, vol. 19, supplement A, pp. 5–36, 2005. View at Google Scholar
  12. C. G. Fedele, M. Ciardi, S. Delia, J. M. Echevarria, and A. Tenorio, “Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples,” Journal of Virological Methods, vol. 82, no. 2, pp. 137–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Muñoz, M. Fogeda, E. Bouza, E. Verde, J. Palomo, and R. Bañares, “Prevalence of BK virus replication among recipients of solid organ transplants,” Clinical Infectious Diseases, vol. 41, pp. 1720–1725, 2005. View at Google Scholar
  14. B. Loeches, M. Valerio, M. Pérez et al., “BK virus in liver transplant recipients: a prospective study,” Transplantation Proceedings, vol. 41, pp. 1033–1037, 2009, Erratum in Transplantation Proceedings, vol. 41, p. 2006, 2009. View at Google Scholar
  15. J. Ledesma, P. Muñoz, D. Garcia de Viedma et al., “BK virus infection in human immunodeficiency virus-infected patients,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 7, pp. 1531–1535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Y. H. Leung, M. Chan, S. C. W. Tang, R. Liang, and Y. L. Kwong, “Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients,” Journal of Virological Methods, vol. 103, no. 1, pp. 51–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Egli, L. Infanti, A. Dumoulin et al., “Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors,” Journal of Infectious Diseases, vol. 199, no. 6, pp. 837–846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bellizzi, V. Barucca, D. Fioriti et al., “Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation,” Journal of Cellular Physiology, vol. 224, no. 2, pp. 316–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Sadiq, L. M. Puccio, and E. W. A. Brydon, “JCV detection in multiple sclerosis patients treated with natalizumab,” Journal of Neurology, vol. 257, no. 6, pp. 954–958, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Lonergan, M. J. Carr, C. F. de Gascun et al., “Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy,” Journal of NeuroVirology, vol. 15, no. 5-6, pp. 351–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Y. H. Leung, M. T. L. Chan, K.-Y. Yuen et al., “Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation,” Clinical Infectious Diseases, vol. 40, no. 4, pp. 528–537, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Koukoulaki, T. Apostolou, V. Hadjiconstantinou, and S. Drakopoulos, “Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication,” Transplant Infectious Disease, vol. 10, no. 6, pp. 449–451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Gabardi, S. S. Waikar, S. Martin et al., “Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 7, pp. 1298–1304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Ali, A. Chandraker, and J. A. DeCaprio, “Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones,” Antiviral Therapy, vol. 12, no. 1, pp. 1–6, 2007. View at Google Scholar · View at Scopus